This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
1 Aug 2012

Auxilium Pharmaceuticals Announces Q2 Financial Results

For the quarter ended June 30, 2012, Auxilium reported net revenues of $78.2 million, compared to net revenues of $65.9 million in the second quarter of 2011, an increase of 19%.

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, has announced financial results for the quarter ending on June 30, 2012. 

 

For the quarter ended June 30, 2012, Auxilium reported net revenues of $78.2 million, compared to net revenues of $65.9 million in the second quarter of 2011, an increase of 19%. 

 

For the second quarter of 2012, U.S. Testim? and XIAFLEX? net revenues increased by 26% and 21% respectively over the comparable 2011 period. 

 

Auxilium reported net income of $7.7 million, or $0.16 per share (basic and fully diluted basis), compared to a net loss of ($5.1) million, or ($0.11) per share, reported for the s

Related News